John Wiley & Sons (NYSE:WLY) Issues FY 2025 Earnings Guidance

John Wiley & Sons (NYSE:WLYGet Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 3.250-3.600 for the period, compared to the consensus EPS estimate of 3.100. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. John Wiley & Sons also updated its FY25 guidance to $3.25-3.60 EPS.

John Wiley & Sons Price Performance

Shares of WLY stock opened at $40.90 on Friday. The firm has a market cap of $2.24 billion, a P/E ratio of -14.20 and a beta of 0.86. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.54 and a quick ratio of 0.50. John Wiley & Sons has a 1-year low of $28.83 and a 1-year high of $43.72. The firm has a fifty day moving average of $37.67 and a two-hundred day moving average of $35.07.

John Wiley & Sons Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 25th. Stockholders of record on Tuesday, April 9th were given a $0.35 dividend. The ex-dividend date was Monday, April 8th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 3.42%. John Wiley & Sons’s payout ratio is currently -48.61%.

Insider Transactions at John Wiley & Sons

In other news, EVP Jay Flynn sold 6,114 shares of the firm’s stock in a transaction dated Wednesday, April 10th. The shares were sold at an average price of $38.82, for a total value of $237,345.48. Following the transaction, the executive vice president now directly owns 8,069 shares in the company, valued at approximately $313,238.58. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.79% of the company’s stock.

About John Wiley & Sons

(Get Free Report)

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.

See Also

Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.